カテゴリ： 世界, 医療/バイオ, QYResearch

脳転移治療薬の世界市場2023年：抗けいれん薬、コルチコステロイド、化学療法薬、その他

■ 英語タイトル：Global Brain Metastases Treatment Drugs Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8702）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8702
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：91
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥435,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥652,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥870,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[脳転移治療薬の世界市場2023年：抗けいれん薬、コルチコステロイド、化学療法薬、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は脳転移治療薬のグローバル市場について調査・分析し、世界の脳転移治療薬市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（抗けいれん薬、コルチコステロイド、化学療法薬、その他）、用途別セグメント分析（がん病院、がん研究センター、診療所）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Bayer AG、Pfizer Inc.、Eli Lilly & Company、Novartis AG、Sanofi、F. Hoffmann-La Roche Ltd.、AstraZeneca、GlaxoSmithKline、Merck & Co., Inc.、AngioChem Inc、Mayo Clinicなどが含まれています。脳転移治療薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、脳転移治療薬市場規模を算出する際に考慮しました。

・脳転移治療薬市場の概要
- 製品の定義
- 脳転移治療薬の種類別セグメント
- 世界の脳転移治療薬市場規模：タイプ別分析（抗けいれん薬、コルチコステロイド、化学療法薬、その他）
- 脳転移治療薬の用途別セグメント
- 世界の脳転移治療薬市場規模：用途別分析（がん病院、がん研究センター、診療所）
- 世界の脳転移治療薬市場規模予測（2018年-2029年）
- 脳転移治療薬の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 脳転移治療薬市場の競争状況およびトレンド

・脳転移治療薬の地域別市場規模
- 北米の脳転移治療薬市場規模（2018年-2029年）
- 米国の脳転移治療薬市場規模（2018年-2029年）
- ヨーロッパの脳転移治療薬市場規模（2018年-2029年）
- アジア太平洋の脳転移治療薬市場規模（2018年-2029年）
- 中国の脳転移治療薬市場規模（2018年-2029年）
- 日本の脳転移治療薬市場規模（2018年-2029年）
- 韓国の脳転移治療薬市場規模（2018年-2029年）
- インドの脳転移治療薬市場規模（2018年-2029年）
- オーストラリアの脳転移治療薬市場規模（2018年-2029年）
- 中南米の脳転移治療薬市場規模（2018年-2029年）
- 中東・アフリカの脳転移治療薬市場規模（2018年-2029年）

・種類別セグメント：抗けいれん薬、コルチコステロイド、化学療法薬、その他
- 世界の脳転移治療薬のタイプ別販売量（2018年-2023年）
- 世界の脳転移治療薬のタイプ別売上（2018年-2023年）
- 世界の脳転移治療薬のタイプ別価格

・用途別セグメント：がん病院、がん研究センター、診療所
- 世界の脳転移治療薬の用途別販売量（2018年-2023年）
- 世界の脳転移治療薬の用途別売上（2018年-2023年）
- 世界の脳転移治療薬の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Bayer AG、Pfizer Inc.、Eli Lilly & Company、Novartis AG、Sanofi、F. Hoffmann-La Roche Ltd.、AstraZeneca、GlaxoSmithKline、Merck & Co., Inc.、AngioChem Inc、Mayo Clinic

・産業チェーンと販売チャネルの分析
- 脳転移治療薬産業チェーン分析
- 脳転移治療薬の主要原材料
- 脳転移治療薬の販売チャネル
- 脳転移治療薬のディストリビューター
- 脳転移治療薬の主要顧客

・脳転移治療薬市場ダイナミクス
- 脳転移治療薬の業界動向
- 脳転移治療薬市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Brain Metastases Treatment Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Brain Metastases Treatment Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Brain Metastases Treatment Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Brain Metastases Treatment Drugs include Bayer AG, Pfizer Inc., Eli Lilly & Company, Novartis AG, Sanofi, F. Hoffmann-La Roche Ltd., AstraZeneca, GlaxoSmithKline and Merck & Co., Inc., etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Brain Metastases Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Metastases Treatment Drugs.
The Brain Metastases Treatment Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Brain Metastases Treatment Drugs market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brain Metastases Treatment Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Bayer AG
Pfizer Inc.
Eli Lilly & Company
Novartis AG
Sanofi
F. Hoffmann-La Roche Ltd.
AstraZeneca
GlaxoSmithKline
Merck & Co., Inc.
AngioChem Inc
Mayo Clinic
Segment by Type
Anticonvulsants
Corticosteroids
Chemotherapy Drugs
Others
Segment by Application
Cancer Hospitals
Cancer Research Centers
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Brain Metastases Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Brain Metastases Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Brain Metastases Treatment Drugs Market Overview
1.1 Product Overview and Scope of Brain Metastases Treatment Drugs
1.2 Brain Metastases Treatment Drugs Segment by Type
1.2.1 Global Brain Metastases Treatment Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Anticonvulsants
1.2.3 Corticosteroids
1.2.4 Chemotherapy Drugs
1.2.5 Others
1.3 Brain Metastases Treatment Drugs Segment by Application
1.3.1 Global Brain Metastases Treatment Drugs Market Value by Application: (2023-2029)
1.3.2 Cancer Hospitals
1.3.3 Cancer Research Centers
1.3.4 Clinics
1.4 Global Brain Metastases Treatment Drugs Market Size Estimates and Forecasts
1.4.1 Global Brain Metastases Treatment Drugs Revenue 2018-2029
1.4.2 Global Brain Metastases Treatment Drugs Sales 2018-2029
1.4.3 Global Brain Metastases Treatment Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Brain Metastases Treatment Drugs Market Competition by Manufacturers
2.1 Global Brain Metastases Treatment Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Brain Metastases Treatment Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Brain Metastases Treatment Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Brain Metastases Treatment Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Brain Metastases Treatment Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Brain Metastases Treatment Drugs, Product Type & Application
2.7 Brain Metastases Treatment Drugs Market Competitive Situation and Trends
2.7.1 Brain Metastases Treatment Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Brain Metastases Treatment Drugs Players Market Share by Revenue
2.7.3 Global Brain Metastases Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Brain Metastases Treatment Drugs Retrospective Market Scenario by Region
3.1 Global Brain Metastases Treatment Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Brain Metastases Treatment Drugs Global Brain Metastases Treatment Drugs Sales by Region: 2018-2029
3.2.1 Global Brain Metastases Treatment Drugs Sales by Region: 2018-2023
3.2.2 Global Brain Metastases Treatment Drugs Sales by Region: 2024-2029
3.3 Global Brain Metastases Treatment Drugs Global Brain Metastases Treatment Drugs Revenue by Region: 2018-2029
3.3.1 Global Brain Metastases Treatment Drugs Revenue by Region: 2018-2023
3.3.2 Global Brain Metastases Treatment Drugs Revenue by Region: 2024-2029
3.4 North America Brain Metastases Treatment Drugs Market Facts & Figures by Country
3.4.1 North America Brain Metastases Treatment Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Brain Metastases Treatment Drugs Sales by Country (2018-2029)
3.4.3 North America Brain Metastases Treatment Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Brain Metastases Treatment Drugs Market Facts & Figures by Country
3.5.1 Europe Brain Metastases Treatment Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Brain Metastases Treatment Drugs Sales by Country (2018-2029)
3.5.3 Europe Brain Metastases Treatment Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Brain Metastases Treatment Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Brain Metastases Treatment Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Brain Metastases Treatment Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Brain Metastases Treatment Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Brain Metastases Treatment Drugs Market Facts & Figures by Country
3.7.1 Latin America Brain Metastases Treatment Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Brain Metastases Treatment Drugs Sales by Country (2018-2029)
3.7.3 Latin America Brain Metastases Treatment Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Brain Metastases Treatment Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Brain Metastases Treatment Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Brain Metastases Treatment Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Brain Metastases Treatment Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Brain Metastases Treatment Drugs Sales by Type (2018-2029)
4.1.1 Global Brain Metastases Treatment Drugs Sales by Type (2018-2023)
4.1.2 Global Brain Metastases Treatment Drugs Sales by Type (2024-2029)
4.1.3 Global Brain Metastases Treatment Drugs Sales Market Share by Type (2018-2029)
4.2 Global Brain Metastases Treatment Drugs Revenue by Type (2018-2029)
4.2.1 Global Brain Metastases Treatment Drugs Revenue by Type (2018-2023)
4.2.2 Global Brain Metastases Treatment Drugs Revenue by Type (2024-2029)
4.2.3 Global Brain Metastases Treatment Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Brain Metastases Treatment Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Brain Metastases Treatment Drugs Sales by Application (2018-2029)
5.1.1 Global Brain Metastases Treatment Drugs Sales by Application (2018-2023)
5.1.2 Global Brain Metastases Treatment Drugs Sales by Application (2024-2029)
5.1.3 Global Brain Metastases Treatment Drugs Sales Market Share by Application (2018-2029)
5.2 Global Brain Metastases Treatment Drugs Revenue by Application (2018-2029)
5.2.1 Global Brain Metastases Treatment Drugs Revenue by Application (2018-2023)
5.2.2 Global Brain Metastases Treatment Drugs Revenue by Application (2024-2029)
5.2.3 Global Brain Metastases Treatment Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Brain Metastases Treatment Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bayer AG
6.1.1 Bayer AG Corporation Information
6.1.2 Bayer AG Description and Business Overview
6.1.3 Bayer AG Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bayer AG Brain Metastases Treatment Drugs Product Portfolio
6.1.5 Bayer AG Recent Developments/Updates
6.2 Pfizer Inc.
6.2.1 Pfizer Inc. Corporation Information
6.2.2 Pfizer Inc. Description and Business Overview
6.2.3 Pfizer Inc. Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Inc. Brain Metastases Treatment Drugs Product Portfolio
6.2.5 Pfizer Inc. Recent Developments/Updates
6.3 Eli Lilly & Company
6.3.1 Eli Lilly & Company Corporation Information
6.3.2 Eli Lilly & Company Description and Business Overview
6.3.3 Eli Lilly & Company Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Eli Lilly & Company Brain Metastases Treatment Drugs Product Portfolio
6.3.5 Eli Lilly & Company Recent Developments/Updates
6.4 Novartis AG
6.4.1 Novartis AG Corporation Information
6.4.2 Novartis AG Description and Business Overview
6.4.3 Novartis AG Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novartis AG Brain Metastases Treatment Drugs Product Portfolio
6.4.5 Novartis AG Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sanofi Brain Metastases Treatment Drugs Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 F. Hoffmann-La Roche Ltd.
6.6.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.6.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.6.3 F. Hoffmann-La Roche Ltd. Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 F. Hoffmann-La Roche Ltd. Brain Metastases Treatment Drugs Product Portfolio
6.6.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.7 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AstraZeneca Brain Metastases Treatment Drugs Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 GlaxoSmithKline
6.8.1 GlaxoSmithKline Corporation Information
6.8.2 GlaxoSmithKline Description and Business Overview
6.8.3 GlaxoSmithKline Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 GlaxoSmithKline Brain Metastases Treatment Drugs Product Portfolio
6.8.5 GlaxoSmithKline Recent Developments/Updates
6.9 Merck & Co., Inc.
6.9.1 Merck & Co., Inc. Corporation Information
6.9.2 Merck & Co., Inc. Description and Business Overview
6.9.3 Merck & Co., Inc. Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Merck & Co., Inc. Brain Metastases Treatment Drugs Product Portfolio
6.9.5 Merck & Co., Inc. Recent Developments/Updates
6.10 AngioChem Inc
6.10.1 AngioChem Inc Corporation Information
6.10.2 AngioChem Inc Description and Business Overview
6.10.3 AngioChem Inc Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 AngioChem Inc Brain Metastases Treatment Drugs Product Portfolio
6.10.5 AngioChem Inc Recent Developments/Updates
6.11 Mayo Clinic
6.11.1 Mayo Clinic Corporation Information
6.11.2 Mayo Clinic Brain Metastases Treatment Drugs Description and Business Overview
6.11.3 Mayo Clinic Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Mayo Clinic Brain Metastases Treatment Drugs Product Portfolio
6.11.5 Mayo Clinic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Brain Metastases Treatment Drugs Industry Chain Analysis
7.2 Brain Metastases Treatment Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Brain Metastases Treatment Drugs Production Mode & Process
7.4 Brain Metastases Treatment Drugs Sales and Marketing
7.4.1 Brain Metastases Treatment Drugs Sales Channels
7.4.2 Brain Metastases Treatment Drugs Distributors
7.5 Brain Metastases Treatment Drugs Customers
8 Brain Metastases Treatment Drugs Market Dynamics
8.1 Brain Metastases Treatment Drugs Industry Trends
8.2 Brain Metastases Treatment Drugs Market Drivers
8.3 Brain Metastases Treatment Drugs Market Challenges
8.4 Brain Metastases Treatment Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Brain Metastases Treatment Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Brain Metastases Treatment Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Brain Metastases Treatment Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Brain Metastases Treatment Drugs Sales (Units) of Key Manufacturers (2018-2023)
Table 5. Global Brain Metastases Treatment Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Brain Metastases Treatment Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Brain Metastases Treatment Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Brain Metastases Treatment Drugs Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Brain Metastases Treatment Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Brain Metastases Treatment Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Brain Metastases Treatment Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Brain Metastases Treatment Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Brain Metastases Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Metastases Treatment Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Brain Metastases Treatment Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Brain Metastases Treatment Drugs Sales by Region (2018-2023) & (Units)
Table 18. Global Brain Metastases Treatment Drugs Sales Market Share by Region (2018-2023)
Table 19. Global Brain Metastases Treatment Drugs Sales by Region (2024-2029) & (Units)
Table 20. Global Brain Metastases Treatment Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Brain Metastases Treatment Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Brain Metastases Treatment Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global Brain Metastases Treatment Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Brain Metastases Treatment Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Brain Metastases Treatment Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Brain Metastases Treatment Drugs Sales by Country (2018-2023) & (Units)
Table 27. North America Brain Metastases Treatment Drugs Sales by Country (2024-2029) & (Units)
Table 28. North America Brain Metastases Treatment Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Brain Metastases Treatment Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Brain Metastases Treatment Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Brain Metastases Treatment Drugs Sales by Country (2018-2023) & (Units)
Table 32. Europe Brain Metastases Treatment Drugs Sales by Country (2024-2029) & (Units)
Table 33. Europe Brain Metastases Treatment Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Brain Metastases Treatment Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Brain Metastases Treatment Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Brain Metastases Treatment Drugs Sales by Region (2018-2023) & (Units)
Table 37. Asia Pacific Brain Metastases Treatment Drugs Sales by Region (2024-2029) & (Units)
Table 38. Asia Pacific Brain Metastases Treatment Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Brain Metastases Treatment Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Brain Metastases Treatment Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Brain Metastases Treatment Drugs Sales by Country (2018-2023) & (Units)
Table 42. Latin America Brain Metastases Treatment Drugs Sales by Country (2024-2029) & (Units)
Table 43. Latin America Brain Metastases Treatment Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Brain Metastases Treatment Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Brain Metastases Treatment Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Brain Metastases Treatment Drugs Sales by Country (2018-2023) & (Units)
Table 47. Middle East & Africa Brain Metastases Treatment Drugs Sales by Country (2024-2029) & (Units)
Table 48. Middle East & Africa Brain Metastases Treatment Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Brain Metastases Treatment Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Brain Metastases Treatment Drugs Sales (Units) by Type (2018-2023)
Table 51. Global Brain Metastases Treatment Drugs Sales (Units) by Type (2024-2029)
Table 52. Global Brain Metastases Treatment Drugs Sales Market Share by Type (2018-2023)
Table 53. Global Brain Metastases Treatment Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Brain Metastases Treatment Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Brain Metastases Treatment Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Brain Metastases Treatment Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global Brain Metastases Treatment Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Brain Metastases Treatment Drugs Price (US$/Unit) by Type (2018-2023)
Table 59. Global Brain Metastases Treatment Drugs Price (US$/Unit) by Type (2024-2029)
Table 60. Global Brain Metastases Treatment Drugs Sales (Units) by Application (2018-2023)
Table 61. Global Brain Metastases Treatment Drugs Sales (Units) by Application (2024-2029)
Table 62. Global Brain Metastases Treatment Drugs Sales Market Share by Application (2018-2023)
Table 63. Global Brain Metastases Treatment Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Brain Metastases Treatment Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Brain Metastases Treatment Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Brain Metastases Treatment Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global Brain Metastases Treatment Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Brain Metastases Treatment Drugs Price (US$/Unit) by Application (2018-2023)
Table 69. Global Brain Metastases Treatment Drugs Price (US$/Unit) by Application (2024-2029)
Table 70. Bayer AG Corporation Information
Table 71. Bayer AG Description and Business Overview
Table 72. Bayer AG Brain Metastases Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Bayer AG Brain Metastases Treatment Drugs Product
Table 74. Bayer AG Recent Developments/Updates
Table 75. Pfizer Inc. Corporation Information
Table 76. Pfizer Inc. Description and Business Overview
Table 77. Pfizer Inc. Brain Metastases Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Pfizer Inc. Brain Metastases Treatment Drugs Product
Table 79. Pfizer Inc. Recent Developments/Updates
Table 80. Eli Lilly & Company Corporation Information
Table 81. Eli Lilly & Company Description and Business Overview
Table 82. Eli Lilly & Company Brain Metastases Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Eli Lilly & Company Brain Metastases Treatment Drugs Product
Table 84. Eli Lilly & Company Recent Developments/Updates
Table 85. Novartis AG Corporation Information
Table 86. Novartis AG Description and Business Overview
Table 87. Novartis AG Brain Metastases Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Novartis AG Brain Metastases Treatment Drugs Product
Table 89. Novartis AG Recent Developments/Updates
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Brain Metastases Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Sanofi Brain Metastases Treatment Drugs Product
Table 94. Sanofi Recent Developments/Updates
Table 95. F. Hoffmann-La Roche Ltd. Corporation Information
Table 96. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 97. F. Hoffmann-La Roche Ltd. Brain Metastases Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. F. Hoffmann-La Roche Ltd. Brain Metastases Treatment Drugs Product
Table 99. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 100. AstraZeneca Corporation Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca Brain Metastases Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. AstraZeneca Brain Metastases Treatment Drugs Product
Table 104. AstraZeneca Recent Developments/Updates
Table 105. GlaxoSmithKline Corporation Information
Table 106. GlaxoSmithKline Description and Business Overview
Table 107. GlaxoSmithKline Brain Metastases Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. GlaxoSmithKline Brain Metastases Treatment Drugs Product
Table 109. GlaxoSmithKline Recent Developments/Updates
Table 110. Merck & Co., Inc. Corporation Information
Table 111. Merck & Co., Inc. Description and Business Overview
Table 112. Merck & Co., Inc. Brain Metastases Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Merck & Co., Inc. Brain Metastases Treatment Drugs Product
Table 114. Merck & Co., Inc. Recent Developments/Updates
Table 115. AngioChem Inc Corporation Information
Table 116. AngioChem Inc Description and Business Overview
Table 117. AngioChem Inc Brain Metastases Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. AngioChem Inc Brain Metastases Treatment Drugs Product
Table 119. AngioChem Inc Recent Developments/Updates
Table 120. Mayo Clinic Corporation Information
Table 121. Mayo Clinic Description and Business Overview
Table 122. Mayo Clinic Brain Metastases Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Mayo Clinic Brain Metastases Treatment Drugs Product
Table 124. Mayo Clinic Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Brain Metastases Treatment Drugs Distributors List
Table 128. Brain Metastases Treatment Drugs Customers List
Table 129. Brain Metastases Treatment Drugs Market Trends
Table 130. Brain Metastases Treatment Drugs Market Drivers
Table 131. Brain Metastases Treatment Drugs Market Challenges
Table 132. Brain Metastases Treatment Drugs Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Brain Metastases Treatment Drugs
Figure 2. Global Brain Metastases Treatment Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Brain Metastases Treatment Drugs Market Share by Type in 2022 & 2029
Figure 4. Anticonvulsants Product Picture
Figure 5. Corticosteroids Product Picture
Figure 6. Chemotherapy Drugs Product Picture
Figure 7. Others Product Picture
Figure 8. Global Brain Metastases Treatment Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Brain Metastases Treatment Drugs Market Share by Application in 2022 & 2029
Figure 10. Cancer Hospitals
Figure 11. Cancer Research Centers
Figure 12. Clinics
Figure 13. Global Brain Metastases Treatment Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Brain Metastases Treatment Drugs Market Size (2018-2029) & (US$ Million)
Figure 15. Global Brain Metastases Treatment Drugs Sales (2018-2029) & (Units)
Figure 16. Global Brain Metastases Treatment Drugs Average Price (US$/Unit) & (2018-2029)
Figure 17. Brain Metastases Treatment Drugs Report Years Considered
Figure 18. Brain Metastases Treatment Drugs Sales Share by Manufacturers in 2022
Figure 19. Global Brain Metastases Treatment Drugs Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Brain Metastases Treatment Drugs Players: Market Share by Revenue in 2022
Figure 21. Brain Metastases Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Brain Metastases Treatment Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Brain Metastases Treatment Drugs Sales Market Share by Country (2018-2029)
Figure 24. North America Brain Metastases Treatment Drugs Revenue Market Share by Country (2018-2029)
Figure 25. United States Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Brain Metastases Treatment Drugs Sales Market Share by Country (2018-2029)
Figure 28. Europe Brain Metastases Treatment Drugs Revenue Market Share by Country (2018-2029)
Figure 29. Germany Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Brain Metastases Treatment Drugs Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Brain Metastases Treatment Drugs Revenue Market Share by Region (2018-2029)
Figure 36. China Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Brain Metastases Treatment Drugs Sales Market Share by Country (2018-2029)
Figure 46. Latin America Brain Metastases Treatment Drugs Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Brain Metastases Treatment Drugs Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Brain Metastases Treatment Drugs Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Brain Metastases Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Brain Metastases Treatment Drugs by Type (2018-2029)
Figure 56. Global Revenue Market Share of Brain Metastases Treatment Drugs by Type (2018-2029)
Figure 57. Global Brain Metastases Treatment Drugs Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Brain Metastases Treatment Drugs by Application (2018-2029)
Figure 59. Global Revenue Market Share of Brain Metastases Treatment Drugs by Application (2018-2029)
Figure 60. Global Brain Metastases Treatment Drugs Price (US$/Unit) by Application (2018-2029)
Figure 61. Brain Metastases Treatment Drugs Value Chain
Figure 62. Brain Metastases Treatment Drugs Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 結膜炎治療薬の世界市場2023年：抗生物質、肥満細胞安定剤、コルチコステロイド、その他
  • 双極性障害治療のグローバル市場展望 2023年-2029年：気分安定薬、抗けいれん薬、抗精神病薬、抗うつ薬、抗不安薬
  • 貧血治療薬の世界市場2023年：サプリメント、抗生物質、免疫抑制剤、骨髄刺激剤、コルチコステロイド、遺伝子治療、鉄キレート剤
  • 血管炎治療のグローバル市場（2022年-2029年）：生物製剤、コルチコステロイド、免疫抑制剤
  • 咳喘息（CVA）治療薬のグローバル市場展望 2023年-2029年：気管支拡張剤、ロイコトリエン拮抗剤、肥満細胞安定剤、コルチコステロイド、モノクローナル抗体
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8702 )"脳転移治療薬の世界市場2023年：抗けいれん薬、コルチコステロイド、化学療法薬、その他" (英文：Global Brain Metastases Treatment Drugs Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。